UASt regulatory sequences drive expression of an inverted repeat.
The expression of ND-42GD6220 under the control of Scer\GAL4ey.PU induces disruption to the patterning of ommatidia; a few eye discs exhibit overgrowths, which comprise both differentiated (neuronal, elav-marked) and mitotic cells.
Whole-eye knockdown of ND-42, through expression of ND-42GD6220 under the control of Scer\GAL4ey.PH leads to lipid droplet accumulation and peroxidation. Aconitase activity is reduced to less than 50% of wild-type in these mutants and there is a strong correlation between decreased aconitase enzymatic activity and the number of lipid droplets per ommatidium, suggesting reactive oxygen species may play a role in lipid droplet accumulation.
Neuronal expression of ND-42GD6220 (under the control of Scer\GAL4elav.PU) causes significant lipid droplet accumulation in glia but not neurons.
Glial expression of ND-42GD6220 (under the control of Scer\GAL454C) does not lead to lipid droplet accumulation.
Newly eclosed flies expressing ND42GD6220 under the control of Scer\GAL4GMR.PU have a normal number and arrangement of rhabdomeres, but the pigment cells are expanded compared to wild type. At 10 days of age, the rhabdomeres are missing or dissociating and the cell bodies of some photoreceptors are vacuolated.
Expression of ND42GD6220 under the control of Scer\GAL4en-e16E results in increased mitochondrial, but not cytosolic, glutathione oxidation in the posterior compartment of the wing disc.
Adults expressing ND-42GD6220 under the control of Scer\GAL4elav.PLu (in the presence of Dcr-2Scer\UAS.cDa to increase the efficiency of RNAi) do not show a significant defect in avoidance of noxious temperature (46[o]C) compared to control flies.
Expression under the control of Scer\GAL4Mef2.PR results in late larval lethality.
Expression under the control of Scer\GAL4Mef2.PR results in grossly normal larval body wall muscles.
Expression under the control of Scer\GAL4Mef2.PR results in wild-type sarcomeres in the larval body wall muscles.
Expression under the control of Scer\GAL4pnr-MD237 results in a colour difference between the central Scer\GAL4pnr-MD237 expression domain of the notum and the surrounding lateral region in 80-90% of the Scer\GAL4pnr-MD237 expression domain.
Expression under the control of Scer\GAL4pnr-MD237 results in bristle morphology defects on the notum in 90-100% of the Scer\GAL4pnr-MD237 expression domain.
Expression under the control of Scer\GAL4pnr-MD237 results in the absence of 10-20% of the Scer\GAL4pnr-MD237-expressing area of the notum.
ND-42GD6220, Scer\GAL4ey.PU has neoplasia | larval stage phenotype, enhanceable by Sod2KK108954, Scer\GAL4ey.PU
ND-42GD6220, Scer\GAL4ey.PU has neoplasia | larval stage phenotype, enhanceable by simaRNAi.UAS.cUa, Scer\GAL4ey.PU
ND-42GD6220, Scer\GAL4ey.PU has neoplasia | larval stage phenotype, enhanceable by Atg18aRNAi.UAS.cUa, Scer\GAL4ey.PU
ND-42GD6220, Scer\GAL4ey.PU has neoplasia | larval stage phenotype, enhanceable by WwoxKK108459, Scer\GAL4ey.PU
ND-42GD6220, Scer\GAL4ey.PU has abnormal neuroanatomy | larval stage phenotype, enhanceable by WwoxKK108459, Scer\GAL4ey.PU
ND-42GD6220, Scer\GAL4ey.PU has increased occurrence of cell division | larval stage phenotype, enhanceable by WwoxKK108459, Scer\GAL4ey.PU
ND-42GD6220, Scer\GAL4ey.PU has neoplasia | larval stage phenotype, enhanceable by Sod1KK102426, Scer\GAL4ey.PU
ND-42GD6220, Scer\GAL4ey.PU has neoplasia | larval stage phenotype, suppressible | partially by foxoUAS.cUa, Scer\GAL4ey.PU
ND-42GD6220, Scer\GAL4ey.PU has neoplasia | larval stage phenotype, suppressible | partially by CatUAS.cAa, Scer\GAL4ey.PU
ND-42GD6220, Scer\GAL4ey.PU has neoplasia | larval stage phenotype, suppressible | partially by Sod1UAS.cUa, Scer\GAL4ey.PU
ND-42GD6220, Scer\GAL4ey.PU has neoplasia | larval stage phenotype, suppressible | partially by Sod2UAS.cUa, Scer\GAL4ey.PU
ND-42GD6220, Scer\GAL4ey.PU has neoplasia | larval stage phenotype, suppressible | partially by AktRNAi.UAS.cUa, Scer\GAL4ey.PU
ND-42GD6220, Scer\GAL4ey.PU has eye phenotype, enhanceable by WwoxKK108459, Scer\GAL4ey.PU
ND-42GD6220, Scer\GAL4ey.PU has eye disc phenotype, enhanceable by WwoxKK108459, Scer\GAL4ey.PU
ND-42GD6220, Scer\GAL4ey.PU has eye disc phenotype, enhanceable by simaRNAi.UAS.cUa, Scer\GAL4ey.PU
ND-42GD6220, Scer\GAL4ey.PU has eye disc phenotype, enhanceable by Atg18aRNAi.UAS.cUa, Scer\GAL4ey.PU
ND-42GD6220, Scer\GAL4ey.PU has eye phenotype, enhanceable by WwoxGD12175, Scer\GAL4ey.PU
ND-42GD6220, Scer\GAL4ey.PU has eye phenotype, enhanceable by Wwox1/Wwox[+]
ND-42GD6220, Scer\GAL4ey.PU has eye disc phenotype, enhanceable by Sod1KK102426, Scer\GAL4ey.PU
ND-42GD6220, Scer\GAL4ey.PU has eye disc phenotype, enhanceable by Sod2KK108954, Scer\GAL4ey.PU
ND-42GD6220, Scer\GAL4ey.PU has eye phenotype, suppressible | partially by WwoxUAS.cCa, Scer\GAL4ey.PU
ND-42GD6220, Scer\GAL4ey.PU has eye disc phenotype, suppressible | partially by CatUAS.cAa, Scer\GAL4ey.PU
ND-42GD6220, Scer\GAL4ey.PU has eye disc phenotype, suppressible | partially by Sod1UAS.cUa, Scer\GAL4ey.PU
ND-42GD6220, Scer\GAL4ey.PU has eye disc phenotype, suppressible | partially by Sod2UAS.cUa, Scer\GAL4ey.PU
ND-42GD6220, Scer\GAL4ey.PU has eye disc phenotype, suppressible | partially by AktRNAi.UAS.cUa, Scer\GAL4ey.PU
ND-42GD6220, Scer\GAL4ey.PU has eye disc phenotype, suppressible | partially by foxoUAS.cUa, Scer\GAL4ey.PU